QBIO
Q BIOMED INC. by Q BioMed Inc. (QBIO)
$00
About Q BIOMED INC. by Q BioMed Inc. (QBIO)
Q BioMed, Inc. operates as a biomedical acceleration and development company. It focuses on acquiring and in-licensing pre-clinical, clinical-stage and approved life sciences therapeutic products. Its products include Strontium-89, MetastronTM, QBM-001, Uttroside-B, and MAN 01. The company was founded by Enrique Navas on November 22, 2013 and is headquartered in New York, NY.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.04
52 Week Low
$0.00
Market cap
14,500
Dividend yield
0.00%
Volume
--
Avg. volume
1,272
P/E ratio
--
Q BIOMED INC. by Q BioMed Inc. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.04
52 Week Low
$0.00
Market cap
14,500
Dividend yield
0.00%
Volume
--
Avg. volume
1,272
P/E ratio
--